Pfizer Joins Other Pharmas in Giving a Cautious Outlook

Pfizer reported fourth-quarter earnings on Tuesday that nearly quadrupled from a year ago as revenue rose 6%. But it also lowered its sales guidance for 2012, due to some of its bestselling drugs going off patent. What’s ahead …

No, the iPad Is Not Killing Microsoft’s Business

Investors are buying into the meme that Windows is dying — and therefore Microsoft is as well. While tablets are clearly cutting into the giant’s core PC business, Microsoft is also showing remarkable agility in building new f…

BP Reinstates Dividend but Problems Linger

BP has benefited from high oil prices and announced it would reinstate its dividend. However, while its fourth-quarter profit was up from a year earlier, the oil giant reported a full-year loss.
Continue readin…